LRRK2 kinase activity regulates Parkinson's disease-relevant lipids at the lysosome.
Saved in:
| Title: | LRRK2 kinase activity regulates Parkinson's disease-relevant lipids at the lysosome. |
|---|---|
| Authors: | Maloney MT; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA., Wang X; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA.; Tenvie Therapeutics, South San Francisco, CA, 94080, USA., Ghosh R; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA., Andrews SV; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA., Maciuca R; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA., Masoud ST; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA., Agam M; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA.; Tenvie Therapeutics, South San Francisco, CA, 94080, USA., Caprioli RM; Mass Spectrometry Research Center, Vanderbilt University, 9160 MRB III, 465 21 Avenue South, Nashville, TN, 37240, USA., Astarita G; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA., Bondar VV; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA., Chen J; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA., Chiu CL; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA., Davis SS; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA., Ho AC; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA., Nguyen HN; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA., Propson NE; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA., Reyzer ML; Mass Spectrometry Research Center, Vanderbilt University, 9160 MRB III, 465 21 Avenue South, Nashville, TN, 37240, USA., Davis OB; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA., Deen MC; Department of Chemistry, Simon Fraser University, Burnaby, BC, V5A 1S6, Canada., Zhu S; Department of Chemistry, Simon Fraser University, Burnaby, BC, V5A 1S6, Canada., Di Paolo G; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA., Vocadlo DJ; Department of Chemistry, Simon Fraser University, Burnaby, BC, V5A 1S6, Canada., Estrada AA; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA.; Tenvie Therapeutics, South San Francisco, CA, 94080, USA., de Vicente J; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA.; Tenvie Therapeutics, South San Francisco, CA, 94080, USA., Lewcock JW; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA., Arguello A; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA., Suh JH; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA., Huntwork-Rodriguez S; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA., Henry AG; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA. henry@dnli.com. |
| Source: | Molecular neurodegeneration [Mol Neurodegener] 2025 Aug 06; Vol. 20 (1), pp. 89. Date of Electronic Publication: 2025 Aug 06. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101266600 Publication Model: Electronic Cited Medium: Internet ISSN: 1750-1326 (Electronic) Linking ISSN: 17501326 NLM ISO Abbreviation: Mol Neurodegener Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40770658 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: LRRK2 kinase activity regulates Parkinson's disease-relevant lipids at the lysosome. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Maloney+MT%22">Maloney MT</searchLink>; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA.; Tenvie Therapeutics, South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Ghosh+R%22">Ghosh R</searchLink>; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Andrews+SV%22">Andrews SV</searchLink>; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Maciuca+R%22">Maciuca R</searchLink>; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Masoud+ST%22">Masoud ST</searchLink>; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Agam+M%22">Agam M</searchLink>; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA.; Tenvie Therapeutics, South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Caprioli+RM%22">Caprioli RM</searchLink>; Mass Spectrometry Research Center, Vanderbilt University, 9160 MRB III, 465 21 Avenue South, Nashville, TN, 37240, USA.<br /><searchLink fieldCode="AU" term="%22Astarita+G%22">Astarita G</searchLink>; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Bondar+VV%22">Bondar VV</searchLink>; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Chen+J%22">Chen J</searchLink>; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Chiu+CL%22">Chiu CL</searchLink>; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Davis+SS%22">Davis SS</searchLink>; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Ho+AC%22">Ho AC</searchLink>; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Nguyen+HN%22">Nguyen HN</searchLink>; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Propson+NE%22">Propson NE</searchLink>; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Reyzer+ML%22">Reyzer ML</searchLink>; Mass Spectrometry Research Center, Vanderbilt University, 9160 MRB III, 465 21 Avenue South, Nashville, TN, 37240, USA.<br /><searchLink fieldCode="AU" term="%22Davis+OB%22">Davis OB</searchLink>; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Deen+MC%22">Deen MC</searchLink>; Department of Chemistry, Simon Fraser University, Burnaby, BC, V5A 1S6, Canada.<br /><searchLink fieldCode="AU" term="%22Zhu+S%22">Zhu S</searchLink>; Department of Chemistry, Simon Fraser University, Burnaby, BC, V5A 1S6, Canada.<br /><searchLink fieldCode="AU" term="%22Di+Paolo+G%22">Di Paolo G</searchLink>; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Vocadlo+DJ%22">Vocadlo DJ</searchLink>; Department of Chemistry, Simon Fraser University, Burnaby, BC, V5A 1S6, Canada.<br /><searchLink fieldCode="AU" term="%22Estrada+AA%22">Estrada AA</searchLink>; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA.; Tenvie Therapeutics, South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22de+Vicente+J%22">de Vicente J</searchLink>; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA.; Tenvie Therapeutics, South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Lewcock+JW%22">Lewcock JW</searchLink>; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Arguello+A%22">Arguello A</searchLink>; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Suh+JH%22">Suh JH</searchLink>; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Huntwork-Rodriguez+S%22">Huntwork-Rodriguez S</searchLink>; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Henry+AG%22">Henry AG</searchLink>; Denali Therapeutics Inc, 161 Oyster Point Blvd, South San Francisco, CA, 94080, USA. henry@dnli.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101266600%22">Molecular neurodegeneration</searchLink> [Mol Neurodegener] 2025 Aug 06; Vol. 20 (1), pp. 89. <i>Date of Electronic Publication: </i>2025 Aug 06. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101266600 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1750-1326 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217501326%22">17501326 </searchLink><i>NLM ISO Abbreviation: </i>Mol Neurodegener <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40770658 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s13024-025-00880-7 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 89 Titles: – TitleFull: LRRK2 kinase activity regulates Parkinson's disease-relevant lipids at the lysosome. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Maloney MT – PersonEntity: Name: NameFull: Wang X – PersonEntity: Name: NameFull: Ghosh R – PersonEntity: Name: NameFull: Andrews SV – PersonEntity: Name: NameFull: Maciuca R – PersonEntity: Name: NameFull: Masoud ST – PersonEntity: Name: NameFull: Agam M – PersonEntity: Name: NameFull: Caprioli RM – PersonEntity: Name: NameFull: Astarita G – PersonEntity: Name: NameFull: Bondar VV – PersonEntity: Name: NameFull: Chen J – PersonEntity: Name: NameFull: Chiu CL – PersonEntity: Name: NameFull: Davis SS – PersonEntity: Name: NameFull: Ho AC – PersonEntity: Name: NameFull: Nguyen HN – PersonEntity: Name: NameFull: Propson NE – PersonEntity: Name: NameFull: Reyzer ML – PersonEntity: Name: NameFull: Davis OB – PersonEntity: Name: NameFull: Deen MC – PersonEntity: Name: NameFull: Zhu S – PersonEntity: Name: NameFull: Di Paolo G – PersonEntity: Name: NameFull: Vocadlo DJ – PersonEntity: Name: NameFull: Estrada AA – PersonEntity: Name: NameFull: de Vicente J – PersonEntity: Name: NameFull: Lewcock JW – PersonEntity: Name: NameFull: Arguello A – PersonEntity: Name: NameFull: Suh JH – PersonEntity: Name: NameFull: Huntwork-Rodriguez S – PersonEntity: Name: NameFull: Henry AG IsPartOfRelationships: – BibEntity: Dates: – D: 06 M: 08 Text: 2025 Aug 06 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1750-1326 Numbering: – Type: volume Value: 20 – Type: issue Value: 1 Titles: – TitleFull: Molecular neurodegeneration Type: main |
| ResultId | 1 |